6 results  1 of 1 

1 Soluble Suppression of Tumorigenicity-2 as a Candidate Prognostic Marker for Stroke: A Systematic Review
Koohyar Ahmadzadeh, Shayan Roshdi Dizaji, Mohammad Balabandian, Hamzah Adel Ramawad, Mahmoud Yousefifard
Ann Lab Med.2023;43(6):585-595.   Published online 2023 June 30     DOI: http://dx.doi.org/10.3343/alm.2023.43.6.585
      
2 Prognostic Role of High-sensitivity Cardiac Troponin I and Soluble Suppression of Tumorigenicity-2 in Surgical Intensive Care Unit Patients Undergoing Non-cardiac Surgery
Hyun Suk Yang, Mina Hur, Ahram Yi, Hanah Kim, Jayoun Kim
Ann Lab Med.2018;38(3):204-211.   Published online 2018 February 2     DOI: http://dx.doi.org/10.3343/alm.2018.38.3.204
      
3 Soluble ST2 Has a Prognostic Role in Patients With Suspected Sepsis
Mina Hur, Hanah Kim, Hyun Jeong Kim, Hyun Suk Yang, Laura Magrini, Rossella Marino, Patrizia Cardelli, Salvatore Di Somma,
Ann Lab Med.2015;35(6):570-577.   Published online 2015 September 1     DOI: http://dx.doi.org/10.3343/alm.2015.35.6.570
      
4 Significance of CD133 as a cancer stem cell markers focusing on the tumorigenicity of pancreatic cancer cell lines
Hyun Joo Lee, Dong Do You, Dong Wook Choi, Young Sil Choi, Seong Joo Kim, Yong Sung Won, Hyoun Jong Moon
J Korean Surg Soc.2011;81(4):263-270.   Published online 2011 October 28     DOI: http://dx.doi.org/10.4174/jkss.2011.81.4.263
   
5 Safety Evaluation of Human Fibroblasts in Mice: Tumorigenicity, 13-week Toxicity and Distribution Studies
Hyung Jun Choi, Euna Kwon, Jeong-Hee Sohn, Jeong-Hwan Che, Kook Hyun Lee, Jong Wan Kim, Jaydo Choi, Byeong-Cheol Kang
Lab Anim Res.2010;26(2):181-196.   Published online 2010 June 17     DOI: http://dx.doi.org/10.5625/lar.2010.26.2.181
   
6 Detection of Cancer by Culturing Cancerous Tissue In Plastico
Won Young Lee, Joo Duek Kim, Byung Soo Kim
Yonsei Med J.1983;24(1):1-5.   Published online 2002 February 20     DOI: http://dx.doi.org/10.3349/ymj.1983.24.1.1
      

 1 of 1